He specialises in all areas of corporate finance and advises businesses on both debt and equity funding. This has included working with innovative companies receiving investment rounds at all stages of their growth (from seed to VC) and then on to listings and trade sales, and also on their banking transactions.
Paul's breadth and depth of knowledge enables him to run deals efficiently and effectively. He has sector expertise in healthcare and life sciences/pharmaceuticals, both from the range of clients he works with at VWV, and also as a result of time spent in-house at AstraZeneca, giving him familiarity with key industry issues.
Paul is also admitted as a solicitor in the British Virgin Islands and so is ideally placed to advise on high value offshore corporate finance work and investment funds, and the issues surrounding these.